High expression of MAP7 predicts the tumor recurrence and adverse outcomes in colon cancer and is related to a poor prognosis in patients with cytogenetically normal acute myeloid leukemia (Blum et al., 2008; Fu et al., 2016). The gene discussed is MAP7; the disease is neoplasm.